Scientists have known for some time that in the early phase of embryogenesis, neural guidance genes also play a role in the development of the vascular system. This is the focus of the research group “Angiogenesis and Cardiovascular Pathology” led by Professor le Noble. Dr. Klein, a member of this research group, discovered during his study of zebrafish that the navigator gene nav3a is also crucial for liver organogenesis.
In the zebrafish embryo, the navigator gene is active in the precursor cells of the liver. If it is missing, the liver cannot develop. The navigator gene, as its name implies, guides the cells in their migration. In a further step the researchers showed that nav3a optimizes cytoskeletal modulation in the cells, precisely orchestrating the migration of the cells to their determined destination, at which they subsequently form the liver. The production of the navigator gene is initiated by the signaling molecule wnt2bb, which belongs to a gene family that has key functions in organogenesis.
First evidence that dysregulated expression of nav3a is involved in liver diseases
The study of developmental processes in zebrafish embryos is also important for research into human diseases. According to Dr. Klein there are first indications “that dysregulated expression of nav3a is involved in the pathogenesis of liver cancer and liver cirrhosis in humans. Nav3a could thus be an important therapeutic target.”
*Neuron navigator 3a regulates liver organogenesis during zebrafish embryogenesis
Christian Klein1, Janine Mikutta1, Janna Krueger1,2, Katja Scholz1, Joep Brinkmann1, Dong Liu1, Justus Veerkamp3, Doreen Siegel4, Salim Abdelilah-Seyfried3 and Ferdinand le Noble1,2,
1Department of Angiogenesis and Cardiovascular Pathology, Max Delbrück Center for Molecular Medicine (MDC), D-13125 Berlin, Germany. 2Center for Stroke Research Berlin (CSB), 10117 Berlin, Germany. 3Department of. Epithelial Polarity and Zebrafish Genetics, Max Delbrück Center for Molecular Medicine (MDC), D-13125 Berlin, Germany. 4Institute of Biochemistry, University of Ulm, D-89091, Ulm, Germany.
*Author for correspondence (email@example.com)
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
13125 Berlin; Germany
Phone: +49 (0) 30 94 06 – 38 96
Fax: +49 (0) 30 94 06 – 38 33